Buy ADB-F for sale online from USA vendor
Discount program: 5% OFF for the second order, 7% OFF for the third order.
Shop with us securely! We offer re-shipment guarantees.
We always provide new, legal products of impeccable quality.
Please make sure that the product is legal in your country and not under any restrictions before ordering.
We do not sell pharmaceutical products or controlled substances.
What is ADB-F?
ADB-F is a synthetic cannabinoid that shares molecular similarities with THC, the principal euphoric ingredient in marijuana. In contrast to THC, produced from the cannabis plant, ADB-F is a laboratory-created synthetic chemical. It is typically used in synthetic cannabis mixes that are touted as legal alternatives to cannabis.
How was ADB-F discovered
ADB-F was detected initially in 2013 in synthetic cannabis mixtures in Japan. Since then, it has been discovered in other nations around the globe, including the United States, Europe, and Australia. The substance is sometimes sold as a legal substitute for marijuana, although it can be far more solid and deadly than its natural cousin.
What are the effects of ADB-F?
ADB-F has comparable effects to THC, including euphoria, relaxation, and altered perception. Nonetheless, the potency of ADB-F can be significantly greater than that of THC, meaning that users may experience more acute and potentially hazardous effects. ADB-F often causes agitation, anxiety, paranoia, hallucinations, and cardiovascular difficulties.
Is ADB-F dangerous
Yes, ADB-F is a potentially hazardous medicine that can result in various severe health issues. ADB-F is a synthetic molecule that has not been appropriately examined, unlike THC, which has been used for thousands of years and is mainly harmless. This indicates that the substance's long-term effects on human health are unclear and may pose grave risks to consumers. Moreover, the strength of ADB-F can vary significantly from batch to batch, so users may not know what they are getting when they take medicine.
FAQ
What are the dangers of using ADB-F?
A higher risk of cardiovascular disorders, such as heart attack and stroke, and mental health issues, such as anxiety, paranoia, and hallucinations, are associated with ADB-F use.
What is the ADB-F format?
ADB-F is a synthetic cannabinoid that shares molecular similarities with THC, the principal euphoric ingredient in marijuana. Typically included in synthetic cannabis mixes and advertised as a legal substitute for cannabis.
How was ADB-F identified?
In 2013, ADB-F was detected for the first time in synthetic cannabis mixtures in Japan. Since then, it has been reported in many nations worldwide.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
